Join the Florida Society of Nephrology as we explore the impact of Medicare Drug Pricing reform enacted in the Inflation Reduction Act of 2022.  

Our guest speaker is Chuck Melendi, Healthcare Policy and Advocacy Director, with Johnson & Johnson.

See the impact the new legislation will have on patient out-of-pocket costs while exploring implications for access to pharmaceutical therapy. 

Some are billing this legislation as the most significant change in Medicare payment policy in decades! 

Don’t miss this opportunity to learn how the new law will impact your practice and patients.

Impact of Medicare Drug Pricing Overhaul: What Physicians Need to Know

Thursday, December 1st at 6 pm, EST

Speaker: Chuck Melendi, Healthcare Policy and Advocacy Director, with Johnson & Johnson.

Register: https://us02web.zoom.us/meeting/register/tZUld-irpz4sEtIzW5MjzHT9--WOwgPtJ_kk  

After registering, you will receive a confirmation email containing information about joining the meeting.